Blog
Wall Street Analysts See a 35.64% Upside in Inogen (INGN): Can the Stock Really Move This High?
Shares of Inogen (INGN) have gained 25.2% over the past four weeks to close the last trading session at $8.11, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts See a 62.07% Upside in Red Robin (RRGB): Can the Stock Really Move This High?
Shares of Red Robin (RRGB) have gained 8.6% over the past four weeks to close the last trading session at $6.17, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts See a 314.81% Upside in Mersana Therapeutics (MRSN): Can the Stock Really Move This High?
Shares of Mersana Therapeutics, Inc. (MRSN) have gained 8.3% over the past four weeks to close the last trading session at $6.82, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 66.13% Upside in Phathom Pharmaceuticals (PHAT): Can the Stock Really Move This High?
Phathom Pharmaceuticals, Inc. (PHAT) closed the last trading session at $12.34, gaining 26.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Does Aligos Therapeutics (ALGS) Have the Potential to Rally 737.74% as Wall Street Analysts Expect?
Shares of Aligos Therapeutics, Inc. (ALGS) have gained 47.5% over the past four weeks to close the last trading session at $11.34, but there could still be a solid upside left in the stock if
Wall Street Analysts Predict a 26.76% Upside in Ategrity Specialty Insurance Company Holdings (ASIC): Here's What You Should Know
Shares of Ategrity Specialty Insurance Company Holdings (ASIC) have gained 11.6% over the past four weeks to close the last trading session at $21.3, but there could still be a solid upside left in
Wall Street Analysts Believe Epam (EPAM) Could Rally 26.37%: Here's is How to Trade
Epam (EPAM) closed the last trading session at $169.46, gaining 7.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe DiaMedica Therapeutics (DMAC) Could Rally 100.81%: Here's is How to Trade
DiaMedica Therapeutics, Inc. (DMAC) closed the last trading session at $6.14, gaining 31.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts Predict a 34.02% Upside in Salesforce.com (CRM): Here's What You Should Know
Shares of Salesforce.com (CRM) have gained 4.3% over the past four weeks to close the last trading session at $250.76, but there could still be a solid upside left in the stock if short-term price
Should You Buy Clean Energy Fuels (CLNE) After Golden Cross?
Clean Energy Fuels Corp. (CLNE) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CLNE's 50-day simple moving average broke out
Werewolf Therapeutics, Inc. (HOWL) Just Flashed Golden Cross Signal: Do You Buy?
Werewolf Therapeutics, Inc. (HOWL) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, HOWL's 50-day simple moving average
Brixmor Property (BRX) Just Flashed Golden Cross Signal: Do You Buy?
From a technical perspective, Brixmor Property Group Inc. (BRX) is looking like an interesting pick, as it just reached a key level of support. BRX's 50-day simple moving average crossed above its
Astria Therapeutics, Inc. (ATXS) Now Trades Above Golden Cross: Time to Buy?
From a technical perspective, Astria Therapeutics, Inc. (ATXS) is looking like an interesting pick, as it just reached a key level of support. ATXS's 50-day simple moving average crossed above its
Should You Buy EuroDry (EDRY) After Golden Cross?
From a technical perspective, EuroDry (EDRY) is looking like an interesting pick, as it just reached a key level of support. EDRY's 50-day simple moving average crossed above its 200-day simple
TransAct Technologies Incorporated (TACT)'s Technical Outlook is Bright After Key Golden Cross
From a technical perspective, TransAct Technologies Incorporated (TACT) is looking like an interesting pick, as it just reached a key level of support. TACT's 50-day simple moving average crossed
Domino's Pizza (DPZ)'s Technical Outlook is Bright After Key Golden Cross
Domino's Pizza Inc (DPZ) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, DPZ's 50-day simple moving average broke out above its
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why Twilio (TWLO) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why Exelixis (EXEL) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates
Why Allegheny Technologies (ATI) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Humana (HUM) is a Top-Ranked Momentum Stock: Should You Buy?
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why Brinker International (EAT) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Carvana (CVNA) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service


